COCRYSTAL PHARMA INC (COCP) Stock Income Statement
NASDAQ:COCP - Nasdaq - US19188J4094 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 16.06M | 18.00M | 21.60M | 18.14M | 14.22M | |||
| Research and Development | 10.95M | N/A | 15.17M | 12.39M | 8.79M | |||
| Selling, General, and Administrative Expenses | 5.11M | 5.34M | 5.99M | 5.75M | 5.43M | |||
| Operating Income | -16.06M | -18.00M | -21.60M | -18.14M | -14.22M | |||
| Interest Income/Expense | 212.00K | N/A | 575.00K | -10.00K | 40.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | 2.60M | -20.69M | N/A | |||
| Income Before Taxes | -15.85M | -18.00M | -18.00M | -38.84M | -14.19M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -15.85M | -18.00M | -18.00M | -38.84M | -14.19M | |||
| EBITDA | -15.95M | -17.87M | -21.41M | -17.95M | -14.03M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.56 | -1.80 | -1.86 | -4.77 | -1.93 | |||
| Non GAAP EPS | -1.57 | -1.73 | -1.90 | -4.73 | -1.92 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD